Efficacy of low dose of rituximab to treat systemic lupus erythematosus.

Front Immunol · 2026 · PMC13314405 · PMID 42382748

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In summary, BEL showed a trend toward improving renal function parameters, whereas RTX caused a significant but clinically acceptable rise in creatinine.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.